DXCM, HOLX And CYH, Pushing Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Two out of the three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 68 points (0.4%) at 17,048 as of Thursday, Aug. 21, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,747 issues advancing vs. 1,215 declining with 171 unchanged.

The Health Services industry currently sits down 0.2% versus the S&P 500, which is up 0.3%. On the negative front, top decliners within the industry include Cyberonics ( CYBX), down 6.5%, and ResMed ( RMD), down 0.7%. Top gainers within the industry include Smith & Nephew ( SNN), up 1.2%, Grifols ( GRFS), up 0.9%, Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.7% and WellPoint ( WLP), up 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. DexCom ( DXCM) is one of the companies pushing the Health Services industry lower today. As of noon trading, DexCom is down $0.85 (-1.9%) to $43.29 on average volume. Thus far, 327,088 shares of DexCom exchanged hands as compared to its average daily volume of 732,300 shares. The stock has ranged in price between $42.98-$44.23 after having opened the day at $44.20 as compared to the previous trading day's close of $44.14.

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. DexCom has a market cap of $3.4 billion and is part of the health care sector. Shares are up 24.6% year-to-date as of the close of trading on Wednesday. Currently there are 9 analysts that rate DexCom a buy, 1 analyst rates it a sell, and 3 rate it a hold.

TheStreet Ratings rates DexCom as a sell. The area that we feel has been the company's primary weakness has been its disappointing return on equity. Get the full DexCom Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Hologic ( HOLX) is down $0.32 (-1.3%) to $25.20 on average volume. Thus far, 700,194 shares of Hologic exchanged hands as compared to its average daily volume of 1.8 million shares. The stock has ranged in price between $25.19-$25.54 after having opened the day at $25.49 as compared to the previous trading day's close of $25.53.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women. Hologic has a market cap of $7.1 billion and is part of the health care sector. Shares are up 14.2% year-to-date as of the close of trading on Wednesday. Currently there are 5 analysts that rate Hologic a buy, 1 analyst rates it a sell, and 12 rate it a hold.

TheStreet Ratings rates Hologic as a hold. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, increase in net income and revenue growth. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full Hologic Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Community Health Systems ( CYH) is down $0.42 (-0.8%) to $51.06 on light volume. Thus far, 640,239 shares of Community Health Systems exchanged hands as compared to its average daily volume of 1.9 million shares. The stock has ranged in price between $50.76-$51.75 after having opened the day at $51.60 as compared to the previous trading day's close of $51.48.

Community Health Systems, Inc., together with its subsidiaries, provides general and specialized hospital healthcare services to patients in the United States. Community Health Systems has a market cap of $5.9 billion and is part of the health care sector. Shares are up 31.1% year-to-date as of the close of trading on Wednesday. Currently there are 13 analysts that rate Community Health Systems a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Community Health Systems as a hold. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and generally higher debt management risk. Get the full Community Health Systems Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

Global Stocks Edge Higher, But Bond Yields, Oil Prices May Test Market Strength

Global Stocks Edge Higher, But Bond Yields, Oil Prices May Test Market Strength

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio